CHICAGO--(BUSINESS WIRE)--Avexis, Inc., a leading gene therapy company developing treatments for rare and life-threatening neurological genetic diseases, today announced recent key appointments to its executive management team. The appointments include Thomas J. Dee, Senior Vice President and Chief Financial Officer; James J. L’Italien, Ph.D., Senior Vice President, Chief Regulatory and Quality Officer; Andrew Knudten, Senior Vice President, Manufacturing and Supply Chain; and Sukumar Nagendran, M.D., Senior Vice President and Chief Medical Officer. These executives will report to Sean P. Nolan, President and CEO of AveXis.
Help employers find you! Check out all the jobs and post your resume.
